Patent · US Active

Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA

US8815825B2 · kind B2 · utility

6Cited by

0References

45Claims

0Family size

Assignee

Dicerna Pharmaceuticals, Inc. · US

Inventors

Bob D. Brown · Littleton, US
Henryk T. Dudek · Wellesley, US

Key dates

Filing date	Dec 18, 2012
Grant date	Aug 26, 2014
Priority date	—
Expiry date	Dec 18, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/30
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This invention relates to compounds, compositions, and methods useful for reducing β-catenin target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.